Search results
Petauri™ Further Expands with Accomplished Evidence and Strategy Executives
WKBN 27 Youngstown· 20 hours agoPetauri, a leading purpose-built pharmaceutical services platform, announced today the addition of Nicole Lodowski and Bob Nordyke to lead a team dedicated to evidence generation ...
Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoProduct liability claims, particularly those related to talc, and allegations related to ...
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoOpportunities for WST lie in expanding global demand for injectable pharmaceuticals and advanced...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoThe company's focus on innovation is evident from its recent acquisition of POINT Biopharma Global...
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
Zacks via Yahoo Finance· 18 hours agoCardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in ...
Global transformation
UB Reporter· 11 hours agoThe interdisciplinary UB students and faculty who visited Ghana in January experienced transformational moments like this throughout their entire...
... 3 Supplements Market Projected to Reach USD 12.96 Billion Globally by 2030 | Top Players –...
Digital Journal· 7 days agoThe global Omega 3 supplements market, valued at USD 6.60 billion in 2022, is poised for significant expansion, estimated to nearly double in value to USD 12.96 billion by ...
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
Rome Sentinel· 2 days agoBURLINGTON, Mass., May 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings which ended on March 31, 2024, on Wednesday, May 8, 2024, after
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
GuruFocus.com via Yahoo Finance· 6 days agoStrategic market expansion can enhance BMRN's global presence and fuel long-term success. R&D...
Earnings call: Novo Nordisk reports a 24% increase in sales By Investing.com
Investing.com· 11 hours agoNovo Nordisk (NYSE:NVO) (NOVO-B.CO), a global healthcare company specializing in diabetes and...